NCT03341676View on ClinicalTrials.gov

Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE)

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
High Altitude Cerebral Edema
Interventions
DRUG

Dexamethasone

Dexamethasone 3.3 mg/mL solution for injection

DRUG

Placebo

Sodium Chloride 0.9% w/v solution for injection

Trial Locations (1)

CV2 2DX

University Hospitals Coventry and Warwickshire NHS Trust, Coventry

All Listed Sponsors
lead

University Hospitals Coventry and Warwickshire NHS Trust

OTHER

NCT03341676 - Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE) | Biotech Hunter | Biotech Hunter